English | 简体中文 | 繁體中文 | 한국어
 Trad. Chinese Press Releases
 Medicine BioTech
KYT Launches Designer Bags for Diabetics
May 02, 2023 23:00 HKT
Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
May 02, 2023 19:00 HKT
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
Apr 27, 2023 20:00 HKT
持續拓展上游供應鏈 金活醫藥參股日本大幸藥品
Apr 25, 2023 08:55 HKT
Avance Clinical 首席執行官加入 2023 年歐洲進化峰會 全球生物製藥小組
Apr 18, 2023 11:00 HKT
壽康集團:Fortacin™╱Senstend™中國第三期隨機臨床試驗取得十分優秀的成果
Apr 17, 2023 22:30 HKT
億勝生物與Osteopore簽訂口腔頜面產品在新加坡的獨家代理協議
Apr 14, 2023 17:19 HKT
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies
Apr 12, 2023 19:30 HKT
金活醫藥授出股份獎勵提升團隊積極性 助力集團高速發展
Apr 11, 2023 15:42 HKT
億勝生物與郡是深圳簽訂皮耐克®可吸收性敷料在中國大陸的獨家代理協議
Apr 11, 2023 12:59 HKT
Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Apr 05, 2023 18:00 HKT
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Apr 04, 2023 17:00 HKT
沛嘉醫療2022年總收入按年升83.7%
Apr 03, 2023 14:53 HKT
中國生物製藥(1177.HK)公佈2022全年業績
Mar 31, 2023 21:12 HKT
金活醫藥2022年經營穩中向好 派末期股息每股2.47港仙
Mar 30, 2023 22:50 HKT
歐康維視公佈2022年全年業績
Mar 30, 2023 22:30 HKT
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市
Mar 30, 2023 20:30 HKT
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT
業聚醫療擬落戶杭州富春灣新城 興建集團最大研發生產設施
Mar 28, 2023 17:29 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: